SJS Investment Consulting’s Amicus Therapeutics FOLD Stock Holding History

SJS Investment Consulting’s Portfolio FOLD Stock Details FOLD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-48	Closed	-$695	–	2923
2026 Q1	$695	Hold	48	–	–	﹤0.01%	1608
2025 Q4	$684	Buy	+48	New	+$472	﹤0.01%	1429

Other funds holding FOLD

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

SJS Investment Consulting's FOLD Position: Q2 2026 in Review

SJS Investment Consulting sold out of Amicus Therapeutics (FOLD) in Q2 2026, closing a stake of 48 shares — an estimated $695 sold.

SJS Investment Consulting first reported a position in FOLD in Q4 2025 and held it in 2 quarters. The position peaked at $695 in Q1 2026. 1 fund tracked by Wall St. Rank holds FOLD as of Q2 2026.

SJS Investment Consulting reported no remaining Amicus Therapeutics position as of Q2 2026 after selling out during the quarter.
SJS Investment Consulting sold 48 Amicus Therapeutics shares in Q2 2026, an estimated $695.
SJS Investment Consulting first reported a position in Amicus Therapeutics in Q4 2025 and held it in 2 quarters.
SJS Investment Consulting's Amicus Therapeutics position peaked at $695 in Q1 2026.
1 fund tracked by Wall St. Rank held Amicus Therapeutics as of Q2 2026.

Based on SJS Investment Consulting's 13F filing for Q2 2026, filed 22 Jul 2026.